Advanced Nanomedicines for the Treatment and Diagnosis of Myocardial Infarction and Heart Failure

E-ISSN： 1873-5592|16|14|1682-1697

ISSN： 1389-4501

Source： Current Drug Targets, Vol.16, Iss.14, 2015-12, pp. : 1682-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regenerative Approaches to Post-Myocardial Infarction Heart Failure

Current Pharmaceutical Design, Vol. 20, Iss. 12, 2014-04 ,pp. : 1930-1940

Bentham Science Publishers

Access to resources Recommend Favorite

Influence of long-term treatment of imidapril on mortality, cardiac function, and gene expression in congestive heart failure due to myocardial infarction

By Ren Bin Shao Qiming Ganguly Pallab K Tappia Paramjit S Takeda Nobuakira Dhalla Naranjan S

Canadian Journal of Physiology and Pharmacology, Vol. 82, Iss. 12, 2004-12 ,pp. : 1118-1127

NRC Research Press

Access to resources Recommend Favorite

Adenylyl cyclase regulation in heart failure due to myocardial infarction in rats

By Bräunig Jörg Albrecht-Küpper Barbara Seifert Roland

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 387, Iss. 4, 2014-04 ,pp. : 389-398

Springer Publishing Company

Access to resources Recommend Favorite

The Therapeutic Potential of Hepatocyte Growth Factor for Myocardial Infarction and Heart Failure

Current Pharmaceutical Design, Vol. 10, Iss. 20, 2004-08 ,pp. : 2525-2533

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced Strategies in the Diagnosis and Treatment of Patients with Coronary Artery Disease and Heart Failure: When Heart Failure Causes Ischemia and Angiotensin Converting Enzyme Inhibitor and Betablockers Helps in Diuresis

Current Pharmaceutical Design, Vol. 24, Iss. 4, 2018-04 ,pp. : 511-516

Bentham Science Publishers

Access to resources Recommend Favorite